The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Valentino Michael J since 2006.
This trader's CIK number is 1319551.
At the time of last reporting, Valentino Michael J was the Executive Chairman of Plx Pharma Inc.. (stock ticker symbol PLXP).
Also see all insider trading activities at Plx Pharma Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | PLXP | 33,000 | $299,760 | 0 | $0 | 0 | $0 |
| 2020 | PLXP | 264,900 | $1,003,176 | 0 | $0 | 0 | $0 |
| 2019 | PLXP | 44,404 | $248,662 | 0 | $0 | 0 | $0 |
| 2017 | PLXP | 29,091 | $200,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | ARXT | 0 | $0 | 70,000 | $4,177,250 | 70,000 | $28,000 |
| 2007 | ARXT | 0 | $0 | 245,000 | $9,811,319 | 245,000 | $98,000 |
| 2006 | ARXT | 0 | $0 | 210,000 | $8,468,651 | 210,000 | $83,999 |
2. Adams Respiratory Therapeutics, Inc. (ARXT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-14 | PLXP | Buy | 8,000 | 12.47 | 99,760 |
| 2021-03-05 | PLXP | Buy | 25,000 | 8.00 | 200,000 |
| 2020-11-18 | PLXP | Buy | 264,900 | 3.79 | 1,003,176 |
| 2019-05-20 | PLXP | Buy | 44,404 | 5.60 | 248,662 |
| 2017-06-14 | PLXP | Buy | 29,091 | 6.88 | 200,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-01-02 | ARXT | Sale | 70,000 | 59.67 | 4,177,250 |
| 2008-01-02 | ARXT | Option Ex | 70,000 | .40 | 28,000 |
| 2007-10-05 | ARXT | Option Ex | 35,000 | .40 | 14,000 |
| 2007-10-05 | ARXT | Sale | 35,000 | 40.00 | 1,400,000 |
| 2007-10-01 | ARXT | Sale | 1,409 | 38.56 | 54,331 |
| 2007-10-01 | ARXT | Sale | 17,891 | 38.26 | 684,581 |
| 2007-10-01 | ARXT | Sale | 15,700 | 37.70 | 591,890 |
| 2007-10-01 | ARXT | Option Ex | 35,000 | .40 | 14,000 |
| 2007-07-03 | ARXT | Sale | 35,000 | 40.13 | 1,404,480 |
| 2007-07-02 | ARXT | Sale | 1,600 | 39.25 | 62,800 |
| 2007-07-03 | ARXT | Option Ex | 35,000 | .40 | 14,000 |
| 2007-07-02 | ARXT | Sale | 33,400 | 39.41 | 1,316,360 |
| 2007-07-02 | ARXT | Option Ex | 35,000 | .40 | 14,000 |
| 2007-05-21 | ARXT | Option Ex | 35,000 | .40 | 14,000 |
| 2007-05-21 | ARXT | Sale | 35,000 | 40.00 | 1,400,000 |
| 2007-01-03 | ARXT | Option Ex | 70,000 | .40 | 28,000 |
| 2007-01-03 | ARXT | Sale | 68,200 | 41.37 | 2,821,706 |
| 2007-01-03 | ARXT | Sale | 1,800 | 41.76 | 75,171 |
| 2006-10-12 | ARXT | Option Ex | 19,300 | .40 | 7,720 |
| 2006-10-13 | ARXT | Option Ex | 15,700 | .40 | 6,280 |
| 2006-10-12 | ARXT | Sale | 19,300 | 40.00 | 772,000 |
| 2006-10-13 | ARXT | Sale | 15,700 | 40.00 | 628,000 |
| 2006-10-02 | ARXT | Sale | 200 | 35.25 | 7,050 |
| 2006-10-02 | ARXT | Sale | 11,401 | 35.91 | 409,444 |
| 2006-10-02 | ARXT | Sale | 23,399 | 35.46 | 829,751 |
| 2006-10-02 | ARXT | Option Ex | 35,000 | .40 | 14,000 |
| 2006-07-03 | ARXT | Option Ex | 16,600 | .40 | 6,640 |
| 2006-07-06 | ARXT | Sale | 13,400 | 43.15 | 578,210 |
| 2006-07-05 | ARXT | Sale | 40,000 | 43.26 | 1,730,400 |
| 2006-07-06 | ARXT | Option Ex | 13,400 | .40 | 5,360 |
| 2006-07-05 | ARXT | Option Ex | 40,000 | .40 | 16,000 |
| 2006-07-03 | ARXT | Sale | 16,600 | 44.09 | 731,894 |
| 2006-04-03 | ARXT | Option Ex | 53,227 | .40 | 21,290 |
| 2006-04-04 | ARXT | Option Ex | 8,628 | .40 | 3,451 |
| 2006-04-03 | ARXT | Sale | 53,227 | 39.66 | 2,110,982 |
| 2006-04-05 | ARXT | Option Ex | 8,145 | .40 | 3,258 |
| 2006-04-04 | ARXT | Sale | 8,628 | 40.00 | 345,120 |
| 2006-04-05 | ARXT | Sale | 8,145 | 40.00 | 325,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valentino Michael J (Executive Chairman of Plx Pharma Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.